955028-90-7

Usage

Uses

Used in Pharmaceutical Industry:
(3R,4R)-rel-tert-Butyl 4-hydroxy-3-methylpiperidine-1-carboxylate is used as a building block for the preparation of pharmaceuticals due to its unique structure and functional groups that can be utilized in the synthesis of various drug molecules.
Used in Organic Synthesis:
(3R,4R)-rel-tert-Butyl 4-hydroxy-3-methylpiperidine-1-carboxylate is used as an intermediate in organic synthesis for the production of other organic compounds, taking advantage of its reactive functional groups and specific stereochemistry.

Upstream product

• 181269-69-2 tert-butyl 3-methyl-4-oxopiperidine-1-carboxylate 
• 33557-57-2 4-hydroxy-3-methylpiperidine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 955028-90-7 (+/-) tert-butyl trans-4-hydroxy-3-methylpiperidine-1-carboxylate 
• 790667-50-4 (+/-)-trans-1-benzyl-3-methylpiperidin-4-ol 
• 34737-89-8 1-Benzyl-3-methyl-4-piperidon 
• 36173-52-1 (3,4-trans)-3-methylpiperidin-4-ol 
• 36173-52-1 (+/-) cis-3-methylpiperidin-4-ol 
• 1159982-52-1 C₁₄H₂₃NO₅ 
• 955028-90-7 rac-(cis)-tert-butyl 4-hydroxy-3-methylpiperidine-1-carboxylate 
• 790667-50-4 (3,4-trans)-1-benzyl-3-methylpiperidin-4-ol 

Downstream Products

• 1421253-15-7 rac-(cis)-tert-butyl 4-methoxy-3-methylpiperidine-1-carboxylate 
• 955028-90-7 (+/-) tert-butyl trans-4-hydroxy-3-methylpiperidine-1-carboxylate 
• 955028-90-7 rac-(cis)-tert-butyl 4-hydroxy-3-methylpiperidine-1-carboxylate 
• 1445796-05-3 C₁₂H₂₃NO₃ 

Relevant academic research and scientific papers

SUBSTITUTED BICYCLIC COMPOUNDS USEFUL AS T CELL ACTIVATORS

Disclosed are compounds of Formula (I): or a salt thereof, wherein: X is CR6 or N; Y is CR3 or N; R1, R2, R3, R4, R5, R6, R7, and m are defined herein. Also disclosed are methods of using such compounds to inhibit the activity of one or both of diacylglycerol kinase alpha (DGKα) and diacylglycerol kinase zeta (DGKζ), and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.

DUAL NAV1.2/5HT2A INHIBITORS FOR TREATING CNS DISORDERS

Compounds of formula I: I are disclosed, as are pharmaceutical compositions containing such compounds. Methods of treating neurological or psychiatric disorders in a patient in need are also disclosed. Such disorders include depression, bipolar disorder, pain, schizophrenia, obsessive compulsive disorder, addiction, social disorder, attention deficit hyperactivity disorder, an anxiety disorder, autism, a cognitive impairment, or a neuropsychiatric symptom such as apathy, depression, anxiety, psychosis, aggression, agitation, impulse control disorders, and sleep disorders in neurological disorders such as Alzheimer's and Parkinson's diseases.

BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS

This invention is directed to benzenesulfonamide compounds, as stereoisomers, enantiomers, tautomers thereof or mixtures thereof; or pharmaceutically acceptable salts, solvates or prodrugs thereof, for the treatment of diseases or conditions associated with voltage-gated sodium channels, such as epilepsy.

6,7-DIHYDRO-5H-PYRROLO[3,4-B]PYRIDIN-5-ONE ALLOSTERIC MODULATORS OF THE M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

The present invention is directed to 6,7-dihydro-5H-pyrrolo[3,4-b]pyridine-5-one compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which M4 muscarinic acetylcholine receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which M4 muscarinic acetylcholine receptors are involved.

PYRROLIDINE GPR40 MODULATORS

The present invention provides compounds of Formula (I): or a stereoisomer, or a pharmaceutically acceptable salt thereof, wherein all of the variables are as defined herein. These compounds are GPR40 G protein-coupled receptor modulators which may be used as medicaments.

THERAPEUTIC COMPOUNDS

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof in which m, n, W, X, Y, Z, R, R1, R2, R3 and R4 are as defined in the specification, for use in therapy.

SULFONYL PIPERIDINE DERIVATIVES AND THEIR USE FOR TREATING PROKINETICIN MEDIATED DISEASES

The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof : (I) in which m, n, W, X, Y, Z, R1, R2, R3 and R4 are as defined in the specification, for use in the treatm

HEPATITIS B ANTIVIRAL AGENTS

The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.

Piperdine derivatives useful as CCR3 antagonists

The use of CCR3 antagonists of the formula I or a pharmaceutically acceptable salt thereof for the treatment of asthma is disclosed, as well as novel compounds of the formula II, pharmaceutical compositions comprising them, and their use in the treatment